Cellectis (CLLS) Accumulated Expenses (2016 - 2024)

Cellectis' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $8.8 million for Q4 2024.

• On a quarterly basis, Accumulated Expenses fell 5.74% year-over-year to $8.8 million in Q4 2024; TTM through Dec 2024 was $8.8 million, a 5.74% decrease from a year earlier, with the FY2024 full-year figure at $8.8 million, down 5.74% from the prior year.
• Accumulated Expenses retreated to $8.8 million in Q4 2024 per CLLS's latest filing, from $9.4 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $9.4 million in Q4 2022 and bottomed at $339000.0 in Q4 2021.
• The 4-year median for Accumulated Expenses is $8.8 million (2024), against an average of $5.7 million.
• Across the five-year window, Accumulated Expenses soared 2679.06% in 2022 and dropped 5.74% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $339000.0 in 2021, then surged by 2679.06% to $9.4 million in 2022, then declined by 0.56% to $9.4 million in 2023, then decreased by 5.74% to $8.8 million in 2024.
• Per Business Quant, the three latest CLLS Accumulated Expenses figures stand at $8.8 million (Q4 2024), $9.4 million (Q4 2023), and $9.4 million (Q4 2022).